Devang Prajapati

Devang Prajapati practices at Kaiser Permanente Fresno Medical Center in Fresno, California, part of Kaiser Permanente.

Devang Prajapati's NPI, 1558396069, was assigned on July 12, 2006. Devang Prajapati graduated from University of Toronto Faculty of Medicine in 1995. Devang Prajapati holds California license A78056.

Devang Prajapati's primary practice is Kaiser Permanente Fresno Medical Center, at 7300 North Fresno St, Fresno, CA 93720 in Fresno County. The practice phone is (559) 448-4500.

Devang Prajapati's primary practice is Kaiser Permanente Fresno Medical Center in Fresno, California, part of Kaiser Permanente. Devang Prajapati is also affiliated with Community Regional Medical Center. The medical group on file is The Permanente Medical Group, Inc. Dmand AI also links Devang Prajapati to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Devang Prajapati practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Devang Prajapati's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Devang Prajapati is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Devang Prajapati's licenses on file in 3 states: California, Wisconsin and Michigan.

CMS data shows 13 Medicare services from Devang Prajapati across 1 procedure code in 2021, for 13 Medicare patients. Medicare paid $1,436 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 13 Medicare patients who saw Devang Prajapati in 2024. Their average risk score is 1.45, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Devang Prajapati's median patient age at 63, with 64% women.

In 2024, Devang Prajapati wrote 517 Medicare Part D claims for 385 patients. 97% of them were for generic drugs. CMS names the drug for 407 of them, across 5 drugs with 11 or more claims each, at $19,745 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Devang Prajapati for performance year 2024, reported as part of a group. Devang Prajapati accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 23 papers to Devang Prajapati, published from 2021 to 2023. 2022 was the busiest year, with 8. The most frequent topics are Medicare, Acute Kidney Injury and Aspirin. Devang Prajapati has published most often in Ann Gastroenterol. Devang Prajapati's most frequent co-authors are Hunza Chaudhry, MD, Aalam Sohal and Sunny Singh Sandhu, MD.

CMS Open Payments shows 4 general payments to Devang Prajapati from 3 drug and device companies from 2016 to 2020. Food and beverage make up the largest share, 100% of the total. Cook Medical LLC paid the most, $37.

Devang Prajapati graduated from University of Toronto Faculty of Medicine in 1995.

Devang Prajapati is in network with 2 carriers, including Kaiser Permanente and CMS Medicare. EPO plans come from the most carriers, 1. Check the plan with the practice before a visit.